|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, The Ohio State University, Columbus, OH.
Correspondence to: Jonathan P. Parsons, MD, Division of Pulmonary and Critical Care Medicine, The Ohio State University, 201 HLRI, 473 W 12th Ave, Columbus, OH 43210; e-mail: Johnathan.Parsons{at}osumc.edu
Exercise-induced bronchoconstriction (EIB) describes airway narrowing that occurs in association with exercise. EIB occurs in up to 90% of asthmatic patients and is estimated to occur in > 10% of the general population. Recent reviews have identified asthma as a risk factor for sudden death and have reported many deaths that have been attributed directly to EIB. We present a review of the literature related to EIB in athletes including sections discussing its pathogenesis, diagnosis, and treatment, and which athletes are most at risk for experiencing EIB.
Key Words: asthma bronchial hyperreactivity exercise-induced bronchospasm exercise test
This article has been cited by other articles:
![]() |
G. Philip, D. S. Pearlman, C. Villaran, C. Legrand, T. Loeys, R. B. Langdon, and T. F. Reiss Single-Dose Montelukast or Salmeterol as Protection Against Exercise-Induced Bronchoconstriction Chest, September 1, 2007; 132(3): 875 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. McD. Johnston Attention to doping controls required when prescribing for athletes. Chest, October 1, 2006; 130(4): 1283 - 1284. [Full Text] [PDF] |
||||
![]() |
T. D. Mickleborough and M. R. Lindley Diet and exercise-induced bronchoconstriction. Chest, August 1, 2006; 130(2): 623 - 624. [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |